Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF

Clinical trial NCT05389215 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05389215
Sponsor: Daewoong Pharmaceutical Co. LTD.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2022-07-29
Primary completion: 2026-10-13
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.